MLAB vs STE
MLAB: Mesa Labs provides essential quality control instruments, consumables, and calibration services to protect patient safety and ensure product integrity in the life sciences and healthcare sectors. STE: STERIS is a global provider of infection prevention and procedural care products and services that help healthcare and life science organizations create a safer, healthier world.
Side-by-side fundamentals
| Metric | MLAB | STE | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $98.57 | $210.57 | |
| Market cap as of 2026-07-23 | $537M | $20.6B | |
| P/E as of 2026-07-23 | 80.05 | 26.28 | STE lower |
| PEG as of 2026-07-23 | n/a | 1.00 | |
| Net margin as of 2026-07-23 | +2.7% | +13.2% | STE higher |
| Gross margin as of 2026-07-23 | +63.5% | +44.3% | MLAB higher |
| Operating margin as of 2026-07-23 | +7.4% | +18.5% | STE higher |
| ROE as of 2026-07-23 | +3.7% | +11.1% | STE higher |
| ROA as of 2026-07-23 | +1.6% | +7.4% | STE higher |
| Debt / equity as of 2026-07-23 | 0.81 | 0.27 | STE lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.4% | +8.7% | STE higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | +9.4% | STE higher |
| Dividend yield as of 2026-07-23 | +0.6% | +1.2% | STE higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-23 | 0.93 | 0.93 | |
| 1-year return as of 2026-07-22 close | +38.1% | -5.9% | MLAB higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.